Intermittent versus daily regimen of prednisolone in ambulatory boys with D uchenne muscular dystrophy: A randomized, open‐label trial-Reference-Cited by-同舟云学术

Intermittent versus daily regimen of prednisolone in ambulatory boys with D uchenne muscular dystrophy: A randomized, open‐label trial

Published:2021-10-18 Issue:1 Volume:65 Page:60-66
ISSN:0148-639X
Container-title:Muscle & Nerve
language:en
Short-container-title:Muscle & Nerve

Author:

Kochar Gurpreet S.¹,Sondhi Vishal²^ORCID,Kabra Sushil K.³,Yadav Shiv L.⁴,Dwivedi Sada N.⁵,Gulati Sheffali⁶

Affiliation:

1. Department of Pediatric Neurology SPS Hospitals Ludhiana India

2. Department of Pediatrics Armed Forces Medical College Pune India

3. Department of Pediatrics All India Institute of Medical Sciences New Delhi India

4. Department of Physical Medicine and Rehabilitation All India Institute of Medical Sciences New Delhi India

5. Department of Biostatistics All India Institute of Medical Sciences New Delhi India

6. Center of Excellence & Advanced Research on Childhood Neurodevelopmental Disorders, Child Neurology Division, Department of Pediatrics All India Institute of Medical Sciences New Delhi India

Publisher

Wiley

Subject

Physiology (medical),Cellular and Molecular Neuroscience,Neurology (clinical),Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mus.27428

Reference21 articles.

1. Population frequencies of inherited neuromuscular diseases—A world survey

2. Evaluating the potential of novel genetic approaches for the treatment of Duchenne muscular dystrophy

3. CINRG randomized controlled trial of creatine and glutamine in Duchenne muscular dystrophy

4. Randomized, blinded trial of weekend vs daily prednisone in Duchenne muscular dystrophy

5. Practice Parameter: Corticosteroid treatment of Duchenne dystrophy: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Feline dystrophin-deficient muscular dystrophy misdiagnosed as Toxoplasma myositis;Journal of Feline Medicine and Surgery Open Reports;2024-07

2. Perspectives on the advances in the pharmacotherapeutic management of Duchenne muscular dystrophy;Expert Opinion on Pharmacotherapy;2022-10-03

3. Deflazacort dose optimization and safety evaluation in Duchenne muscular dystrophy (DOSE): A randomized, double-blind non-inferiority trial;European Journal of Paediatric Neurology;2022-05